IQV - Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment | Benzinga
IQVIA Holdings Inc (NYSE:IQV) reported fourth-quarter 2023 sales of $3.87 billion, up 3.5% Y/Y on a reported basis and 2.6% at constant currency (CC), beating the management guidance of $3.769 billion-$3.804 billion and the consensus of $3.79 billion.
IQVIA reported adjusted EPS of $2.84 compared to the management guidance of $2.79-$2.86, beating the consensus of $2.82.
Technology & Analytics Solutions revenue increased 2.1% (1.3% CC) to $1.53 billion. Research & Development Solutions (R&DS) sales reached $2.15 billion, +4.5% (3.7% CC).
Contract Sales & Medical Solutions revenue reached $186 ...